Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer-Reference-Cited by-同舟云学术

Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer

Published:2022-09-02 Issue:17 Volume:82 Page:3187-3187
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:

Author:

Brand Toni M.,Hartmann Stefan,Bhola Neil E.,Li Hua,Zeng Yan,O'Keefe Rachel A.,Ranall Max V.,Bandyopadhyay Sourav,Soucheray Margaret,Krogan Nevan J.,Kemp Carolyn,Duvvuri Umamaheswar,LaVallee Theresa,Johnson Daniel E.,Ozbun Michelle A.,Bauman Julie E.,Grandis Jennifer R.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Link

https://aacrjournals.org/cancerres/article-pdf/82/17/3187/3196662/3187.pdf

Reference2 articles.

1. Cross-talk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer;Brand;Cancer Res,2018

2. Cross-talk signaling between HER3 and HPV16 E6 and E7 mediates resistance to PI3K inhibitors in head and neck cancer;Brand;Cancer Res,2022

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of PI3K/AKT signaling pathway involved in self-renewing and maintaining biological properties of chicken primordial germ cells;Poultry Science;2024-11

2. HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor;Cancer Gene Therapy;2023-12-15

3. Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer;Cancer Research;2022-09-02

4. Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer;Cancer Research;2022-09-02